Literature DB >> 8077964

Vasopressin-induced neurotrophism in cultured hippocampal neurons via V1 receptor activation.

R D Brinton1, A W Monreal, J G Fernandez.   

Abstract

Structural enhancement of nerve cell morphology has been postulated to be an integral step in the cellular process leading to information storage in the nervous system. To investigate this postulate, we determined whether vasopressin (AVP), a neural peptide that can enhance memory function, would enhance the cytoarchitectural features of hippocampal neurons in culture. Results of these studies demonstrated that in the presence of serum, vasopressin (1 microM), induced a significant increase in the number of neurites, in neuritic length, and in neurite diameter following 48 h of exposure. Morphological complexity was also enhanced following vasopressin exposure as indicated by a significant increase in the number of filopodia/branches, in the sum of branch lengths, and in the number of branch bifurcation points. The number of microspikes decorating neuritic branches was also significantly increased following vasopressin exposure. To determine whether the neurotrophic effect of vasopressin was dependent upon factors present in serum, hippocampal nerve cells were cultured in serum-free media and exposed to 100-1000 nM AVP. Results of these studies demonstrated that in the absence of serum, AVP induced significant enhancement of hippocampal nerve cell growth and that the minimally effective concentration was reduced from 1 microM, as required in the presence serum, to 100 nM. In addition, the time required for a significant increase in nerve cell growth to become apparent decreased from 48 to 24 h. These results demonstrate that AVP-induced neurotrophism is not dependent upon unidentified factors in serum. AVP-induced neurotrophism was found to be mediated by V1 receptor activation. Significant enhancement of nerve cell growth occurred following exposure to V1 receptor agonist (100-1000 nM), whereas exposure to V2 receptor agonist (100-1000 nM) did not increase any of the morphological parameters measured. Considered together, these data indicate that vasopressin can exert a significant neurotrophic effect upon hippocampal nerve cells in culture. Moreover, AVP-induced neurotrophism is a direct effect and not dependent upon unidentified factors present in serum. Enhancement of hippocampal nerve cell growth occurred in the presence of a specific V1 receptor agonist and not following exposure to a V2 agonist, suggesting that activation of the phosphatidyl inositol pathway via V1 receptor activation mediates AVP-induced neurotrophism. Results of these studies are discussed with respect to their implications for understanding vasopressin involvement during neural development and induction of cytoarchitectural modifications associated with memory formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077964     DOI: 10.1002/neu.480250404

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  5 in total

1.  Interplay between presynaptic and postsynaptic activities is required for dendritic plasticity and synaptogenesis in the supraoptic nucleus.

Authors:  Vivien Chevaleyre; Francoise C Moos; Michel G Desarménien
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

2.  Vasopressin protects hippocampal neurones in culture against nutrient deprivation or glutamate-induced apoptosis.

Authors:  J Chen; G Aguilera
Journal:  J Neuroendocrinol       Date:  2010-10       Impact factor: 3.627

3.  17 beta-Estradiol enhances the outgrowth and survival of neocortical neurons in culture.

Authors:  R D Brinton; J Tran; P Proffitt; M Montoya
Journal:  Neurochem Res       Date:  1997-11       Impact factor: 3.996

4.  Anti-apoptotic actions of vasopressin in H32 neurons involve MAP kinase transactivation and Bad phosphorylation.

Authors:  Jun Chen; Simona Volpi; Greti Aguilera
Journal:  Exp Neurol       Date:  2008-03-10       Impact factor: 5.330

5.  Homeostatic capabilities of the choroid plexus epithelium in Alzheimer's disease.

Authors:  Conrad Johanson; Paul McMillan; Rosemarie Tavares; Anthony Spangenberger; John Duncan; Gerald Silverberg; Edward Stopa
Journal:  Cerebrospinal Fluid Res       Date:  2004-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.